1 Department of Pediatrics, College of Medicine and King Khalid University Hospital (KKUH), King Saud University, Riyadh, Saudi Arabia.
2 King Khalid University Hospital (KKUH), King Saud University, Riyadh, Saudi Arabia.
3 College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Received on 17 May 2023; revised on 23 June 2023; accepted on 26 June 2023
The syndrme of apparent mineralocorticoid excess (AME) is an extremly. rare autosomal recessive disorder. To date, more than 100 reported cases in the medical literature world-wide. It is caused by an impairment in the enzym 11-b-hydroxy steroid dehydrogenase (11-b-HSD) enzyme type 2, characterized by early onset hypertension, hypokalemia, metabolic alkalosis, low levels of seum renin and aldosterone. The majority of patients are usually have a low birth weight and failure to thrive (FTT). Nephrocalcinosis could be present. We describe an 11.5 year old girl, who presented in early infancy with poor growth, and not until a gene study done recently, which revealed a homozygous pathogenic variant in the HSD 11B2 gene c. 622 C >Tp. (Arg208 Cys ). This is consistent with the diagnosis of AME This emphasizes the importance of genetic testing in the diagnosis of AME. A high index of suspicion required in managing such patients. Increased awarness among health care professionals is needed to avoid potential health hazards.
Apparent Mineralocorticoid Excess (AME); 11-b-Hydroxy Steroid Dehydrogenase Enzyme 2; (11-b- HSD2); Hypokalemia; Alkalosis; Renin; Aldosterone; Failure to thrive (FTT); Genetic study
Get Your e Certificate of Publication using below link
Preview Article PDF
Amirah D. Albalawi, Sharifah D.A Al-Issa, Mohammed Ahmed AlHissi , Abdulrahman N A Aljurayyan, Jumana J Khoder and Nasir A M Al-Jurayyan. Hereditary forms of apparent mineralocorticoid excess (AME): Report of a further case and literature review. World Journal of Biology Pharmacy and Health Sciences, 2023, 15(01), 180–184. Article DOI: https://doi.org/10.30574/wjbphs.2023.15.1.0284